Please use this identifier to cite or link to this item:
|Title:||Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab|
|Authors:||Simes, Robert John|
Cutsem, E Van
De Roock, Wendy
Di Nicolantonio, Federica
Jonker, Derek J.
School of Public Health: NH&MRC Clinical Trials Centre
|Publisher:||American Medical Association|
|Citation:||Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab, JAMA: The Journal of the American Medical Association, vol.304, 16,pp 1812-1820|
|Department/Unit/Centre:||School of Public Health: NH&MRC Clinical Trials Centre|
|Disclaimer:||This work has been made available to the staff and students of the University of Sydney for the purposes of research and study only. It constitutes material that is held by the University for the purposes of reporting for HERDC and the ERA. This work may not be downloaded, copied and distributed to any third party .|
|Type:||C1 - Refereed Journal articles|
|Appears in Collections:||University of Sydney Research Outputs|
Items in Sydney Research Online are protected by copyright, with all rights reserved, unless otherwise indicated.